Eli Lilly and Co (LLY)
730.61
-15.34
(-2.06%)
USD |
NYSE |
Apr 19, 13:47
Eli Lilly Gross Profit (Quarterly): 7.565B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.565B |
September 30, 2023 | 7.638B |
June 30, 2023 | 6.505B |
March 31, 2023 | 5.333B |
December 31, 2022 | 5.754B |
September 30, 2022 | 5.362B |
June 30, 2022 | 5.058B |
March 31, 2022 | 5.738B |
December 31, 2021 | 5.950B |
September 30, 2021 | 5.342B |
June 30, 2021 | 4.787B |
March 31, 2021 | 4.927B |
December 31, 2020 | 5.720B |
September 30, 2020 | 4.414B |
June 30, 2020 | 4.277B |
March 31, 2020 | 4.645B |
December 31, 2019 | 4.831B |
September 30, 2019 | 4.302B |
June 30, 2019 | 4.512B |
March 31, 2019 | 3.954B |
December 31, 2018 | 4.508B |
September 30, 2018 | 4.154B |
June 30, 2018 | 4.351B |
March 31, 2018 | 3.799B |
December 31, 2017 | 3.321B |
Date | Value |
---|---|
September 30, 2017 | 4.072B |
June 30, 2017 | 4.253B |
March 31, 2017 | 3.880B |
December 31, 2016 | 4.239B |
September 30, 2016 | 3.791B |
June 30, 2016 | 3.940B |
March 31, 2016 | 3.542B |
December 31, 2015 | 3.986B |
September 30, 2015 | 3.723B |
June 30, 2015 | 3.760B |
March 31, 2015 | 3.452B |
December 31, 2014 | 3.868B |
September 30, 2014 | 3.609B |
June 30, 2014 | 3.746B |
March 31, 2014 | 3.460B |
December 31, 2013 | 4.422B |
September 30, 2013 | 4.574B |
June 30, 2013 | 4.764B |
March 31, 2013 | 4.444B |
December 31, 2012 | 4.709B |
September 30, 2012 | 4.240B |
June 30, 2012 | 4.454B |
March 31, 2012 | 4.404B |
December 31, 2011 | 4.725B |
September 30, 2011 | 4.810B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.277B
Minimum
Jun 2020
7.638B
Maximum
Sep 2023
5.403B
Average
5.333B
Median
Mar 2023
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 5.084B |
Madrigal Pharmaceuticals Inc | -- |
Vertex Pharmaceuticals Inc | 2.150B |
Viking Therapeutics Inc | -- |
Moderna Inc | 1.884B |